Document is current
Any future updates will be listed below
-
Authors
Parati, Gianfranco
Ogedegbe, Gbenga
Agiro, Abiy
Luan, Shan
Davis, Harrison
Daniel, Ian
McKendrick, Jan
Huang, Joanna
Townsend, Raymond R. https://orcid.org/0000-0002-3215-9118
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 26 November 2025
Accepted: 6 February 2026
First Online: 18 March 2026
Declarations
:
: Abiy Agiro, Shan Luan, and Joanna Huang are employees and stockholders of AstraZeneca. Gianfranco Parati has received honoraria for lectures from Omron, SOMNOmedics AG, Merck, and Viatris. Gbenga Ogedegbe is funded by the American Heart Association and the National Institutes of Health (NHLBI, NIMHD, AHRQ, and PCORI). He also received honorarium from AstraZeneca as a Visiting Professor to discuss strategies to address health inequities in hypertension. Harrison Davis, Ian Daniel, and Jan McKendrick were employees of Avalere Health, which is a consulting firm that received payment from AstraZeneca to conduct the study, at the time the study was undertaken. Raymond R. Townsend received consulting fees from Medtronic, Regeneron, Bard, Orchestra Backbeat, Idorsia and AstraZeneca; serves on DSMBs for Cytel, Novartis and E*Star; and received royalty income from UpToDate.
: This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.
